Literature DB >> 22990217

Assigning dose of nicotine gum by time to first cigarette.

Saul Shiffman1, Mark A Sembower, Jeffrey M Rohay, Joe G Gitchell, Arthur J Garvey.   

Abstract

INTRODUCTION: Nicotine gum, a proven effective aid to cessation, comes in two doses: 2-mg and 4-mg. Assignment to the higher dose has traditionally been based on daily cigarette consumption. This paper evaluates efficacy of the gum when the 4-mg dose is assigned based on time to first cigarette (TTFC) being ≤ 30 min.
METHODS: In a secondary analysis of a randomized, double-blind, placebo-controlled trial that allocated smokers randomly to placebo, 2-mg, or 4-mg gum (Garvey, A. J., Kinnunen, T., Nordstrom, B. L., Utman, C. H., Doherty, K., Rosner, B., et al. (2000). Effects of nicotine gum dose by level of nicotine dependence. Nicotine & Tobacco Research, 2, 53-63. doi:10.1080/14622200050011303), we evaluated outcomes when 4-mg gum was given to subjects with TTFC ≤ 30 (n = 158, placebo n = 159).
RESULTS: Active treatment doubled or tripled abstinence rates versus placebo. This also held among smokers with a history of treatment failure. The effect of 4-mg gum was significant among light smokers (<25 CPD) with TTFC ≤ 30; 2-mg gum was not.
CONCLUSION: This analysis suggests that assigning dose of nicotine gum based on TTFC is an effective and appropriate means of dose allocation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22990217     DOI: 10.1093/ntr/nts141

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  7 in total

1.  Time to first cigarette predicts cessation outcomes in adolescent smokers.

Authors:  Melissa Mercincavage; Steven A Branstetter; Joshua E Muscat; Kimberly A Horn
Journal:  Nicotine Tob Res       Date:  2013-06-28       Impact factor: 4.244

2.  Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.

Authors:  Nicola Lindson; Samantha C Chepkin; Weiyu Ye; Thomas R Fanshawe; Chris Bullen; Jamie Hartmann-Boyce
Journal:  Cochrane Database Syst Rev       Date:  2019-04-18

Review 3.  Tobacco Use Disorder.

Authors:  Frank T Leone; Sarah Evers-Casey
Journal:  Med Clin North Am       Date:  2022-01       Impact factor: 5.456

4.  Exploring the Severity of Dependence Scale (SDS) as a possible measure of nicotine dependence.

Authors:  Melissa Mercincavage; Joshua M Smyth; Steven A Branstetter; Delwyn Catley
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

Review 5.  Nicotine replacement therapy versus control for smoking cessation.

Authors:  Jamie Hartmann-Boyce; Samantha C Chepkin; Weiyu Ye; Chris Bullen; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2018-05-31

Review 6.  Optimal use of smoking cessation pharmacotherapy.

Authors:  Colin Mendelsohn
Journal:  Aust Prescr       Date:  2022-02-01

7.  Time to First Cigarette: A Potential Clinical Screening Tool for Nicotine Dependence.

Authors:  Steven A Branstetter; Joshua E Muscat; Melissa Mercincavage
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 4.647

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.